Press release
Actinic Keratosis Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Prevalence, Medication, Therapies, NICE Approvals and Companies by DelveInsight
Actinic Keratosis Drugs Market
(Albany, USA) DelveInsight's "Actinic Keratosis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Actinic Keratosis, historical and forecasted epidemiology as well as the Actinic Keratosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Actinic Keratosis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Actinic Keratosis market size from 2020 to 2034, segmented by seven major markets. The Report also covers current Actinic Keratosis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Actinic Keratosis market.
Request for a Free Sample Report @ Actinic Keratosis Market Forecast [https://www.delveinsight.com/report-store/actinic-keratosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Some facts of the Actinic Keratosis Market Report are:
* According to DelveInsight, Actinic Keratosis market size is expected to grow at a decent CAGR by 2034.
* Leading Actinic Keratosis companies working in the market are VidacPharma, DFB Soria, G&E Herbal Biotechnology, Promius Pharma, Sol-Gel Technologies, PROVECTUS BIOPHARMACEUTICALS, Coegin Pharma, Jupiter Wellness, MedC Biopharma CorporationGlaukos Corporation, Ivantis Inc., Allergan, Ellex, Alcon, BVI, Johnson and Johnson Services, Inc., Microsurgical technology, Molteno Ophthalmic Ltd. ,New World Medical , Santen Pharmaceutical, Sight Scientific, Topcon Corporation, Merck & Co., Inc., Carl Zeiss AG, Alimera Sciences, Annexin Pharmaceuticals, Amgen Inc., Cangene Corporation, BD and Bosch Healthcare Solutions GmbH among others.
* Key Actinic Keratosis Therapies expected to launch in the market are AVX001, VDA-1102, and others.
* In February 2025, Almirall, S.A announced results of a Phase 3, Multicentre, Randomised, Double-blind, Vehicle-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Tirbanibulin 10 mg/g Ointment Applied to a Treatment Field Larger Than 25 cm^2 and up to 100 cm^2 in Adult Patients With Actinic Keratosis
* In November 2024, Vidac Pharma has secured 600,000 ($645,651) in additional funding to advance the clinical development of its two lead cancer candidates. Announced during the company's recent shareholder meeting, this funding from existing investors will allow Vidac to initiate a new Phase IIb trial for its lead candidate, VDA-1102 (tuvatexib) ointment. The hexokinase 2 inhibitor is being studied for its potential in treating advanced cases of actinic keratosis, a skin condition that may progress to cutaneous squamous cell carcinoma (SCC).
* In May 2024, TORQUR announced results of a Randomized Phase 2 Proof-of-Concept Study to Evaluate the Efficacy and Safety of Topical Bimiralisib Application in Participants Suffering From Actinic Keratosis on the Face and/or Scalp and/or Back of Hands Over a 2 and 4-week Treatment Period
* Additionally, the launch of new therapies such as VDA-1102, SR-T100 Gel, and other innovative topical treatments is anticipated to enhance treatment outcomes and broaden market prospects.
* According to Chetty P et al., the prevalence of AK varies from 6-60%, depending on age, phototype and other predisposing risk factors (most notably immunosuppressed status, outdoor workers), and is increasing
* In a study conducted by Schaefer et al., it was found that the standardized prevalence of AK from dermatological examinations was 2.7%; the rate increased with age (11.5% in the group 60-70 years) and was higher for men (3.9%) than for women (1.5%)
Actinic Keratosis Overview
Actinic keratosis (AK) is a common skin condition characterized by rough, scaly patches that develop due to long-term exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Actinic keratosis usually occurs on areas of the body that receive the most sun exposure, such as the face, scalp, ears, neck, and hands.
These lesions are usually small, red, or flesh-colored, with a rough texture resembling sandpaper. While actinic keratosis is not cancerous in itself, it is considered a precancerous condition, as a small percentage of Actinic keratosis may progress to squamous cell carcinoma, a type of skin cancer.
It is important to have Actinic keratosis evaluated and treated by a healthcare professional. Treatment options include topical creams, cryotherapy (freezing), chemical peels, photodynamic therapy, or surgical removal. Prevention is crucial, and measures such as sun protection (using sunscreen, wearing protective clothing, and seeking shade), regular skin examinations, and avoiding artificial UV radiation can help reduce the risk of developing actinic keratosis. Early detection and treatment of Actinic keratosis can significantly lower the risk of skin cancer.
Learn more about Actinic Keratosis treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ [https://www.delveinsight.com/sample-request/actinic-keratosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Actinic Keratosis Market
The Actinic Keratosis market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Actinic Keratosis market trends by analyzing the impact of current Actinic Keratosis therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.
This segment gives a thorough detail of the Actinic Keratosis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Actinic Keratosis market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Actinic Keratosis market in 7MM is expected to witness a major change in the study period 2020-2034.
Actinic Keratosis Epidemiology
The Actinic Keratosis epidemiology section provides insights into the historical and current Actinic Keratosis patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Actinic Keratosis market report also provides the diagnosed patient pool, trends, and assumptions.
Explore more about Actinic Keratosis Epidemiology @ [https://www.delveinsight.com/sample-request/actinic-keratosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Actinic Keratosis Drugs Uptake
This section focuses on the uptake rate of the potential Actinic Keratosis drugs recently launched in the Actinic Keratosis market or expected to be launched in 2020-2034. The analysis covers the Actinic Keratosis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Actinic Keratosis Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Actinic Keratosis market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Actinic Keratosis Pipeline Development Activities
The Actinic Keratosis report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Actinic Keratosis key players involved in developing targeted therapeutics.
Learn more about the emerging Actinic Keratosis Market drivers and barriers @ [https://www.delveinsight.com/sample-request/actinic-keratosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Actinic Keratosis Therapeutics Assessment
Major key companies are working proactively in the Actinic Keratosis Therapeutics market to develop novel therapies which will drive the Actinic Keratosis treatment markets in the upcoming years are VidacPharma, DFB Soria, G&E Herbal Biotechnology, Promius Pharma, Sol-Gel Technologies, PROVECTUS BIOPHARMACEUTICALS, Coegin Pharma, Jupiter Wellness, MedC Biopharma CorporationGlaukos Corporation, Ivantis Inc., Allergan, Ellex, Alcon, BVI, Johnson and Johnson Services, Inc., Microsurgical technology, Molteno Ophthalmic Ltd. ,New World Medical , Santen Pharmaceutical, Sight Scientific, Topcon Corporation, Merck & Co., Inc., Carl Zeiss AG, Alimera Sciences, Annexin Pharmaceuticals, Amgen Inc., Cangene Corporation, BD and Bosch Healthcare Solutions GmbH among others.
Learn more about the emerging Actinic Keratosis therapies & key companies @ Actinic Keratosis Therapies and Companies [https://www.delveinsight.com/sample-request/actinic-keratosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Actinic Keratosis Report Key Insights
1. Actinic Keratosis Patient Population
2. Actinic Keratosis Market Size and Trends
3. Key Cross Competition in the Actinic Keratosis Market
4. Actinic Keratosis Market Dynamics (Key Drivers and Barriers)
5. Actinic Keratosis Market Opportunities
6. Actinic Keratosis Therapeutic Approaches
7. Actinic Keratosis Pipeline Analysis
8. Actinic Keratosis Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Actinic Keratosis Market
Table of Contents
1. Key Insights
2. Executive Summary
3. Actinic Keratosis Competitive Intelligence Analysis
4. Actinic Keratosis Market Overview at a Glance
5. Actinic Keratosis Disease Background and Overview
6. Actinic Keratosis Patient Journey
7. Actinic Keratosis Epidemiology and Patient Population
8. Actinic Keratosis Treatment Algorithm, Current Treatment, and Medical Practices
9. Actinic Keratosis Unmet Needs
10. Key Endpoints of Actinic Keratosis Treatment
11. Actinic Keratosis Marketed Products
12. Actinic Keratosis Emerging Therapies
13. Actinic Keratosis Seven Major Market Analysis
14. Attribute Analysis
15. Actinic Keratosis Market Outlook (7 major markets)
16. Actinic Keratosis Access and Reimbursement Overview
17. KOL Views on the Actinic Keratosis Market
18. Actinic Keratosis Market Drivers
19. Actinic Keratosis Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=actinic-keratosis-drugs-market-2034-clinical-trials-ema-pdma-fda-approvals-prevalence-medication-therapies-nice-approvals-and-companies-by-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/ats-conference-coverage
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Actinic Keratosis Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Prevalence, Medication, Therapies, NICE Approvals and Companies by DelveInsight here
News-ID: 4033285 • Views: …
More Releases from ABNewswire
New YA Adventure "Milly and the Shawl of Athena" Transports Young Readers into a …
A gripping new teen and adventure novel has hit the shelves. Milly and the Shawl of Athena by J P Allen is a genre-defying novel which combines ancient mythology, gaming culture, and heart-wrenching family drama to produce an addictive adventure.
Set in a decade and inspired by the author's love of history, mythology, fiction, and computer games, this first in the planned series features twelve-year-old Milly Martin, whose ordinary life is…
Hudkins Publishing Music Launches Three Volumes of Background Music for Commerci …
Now they are available for every business.
KINGMAN, AZ - October 30, 2025 - Hudkins Publishing Music proudly announces the release of three new instrumental playlists explicitly designed for commercial use in cafes, offices, spas, restaurants, hotels, and creative studios. The new series-Hudkins Background Music Volumes 1-3-offers businesses royalty-free soundtracks that elevate atmosphere, encourage customer relaxation, and improve employee focus.
Each collection features 30 professionally produced instrumental tracks, available in both WAV…
Book Now the Emerging Gospel Artist "Jacqueline L. Jenkins" debuts new single "A …
BIOGRAPHY
Jacqueline L. Jenkins is an emerging gospel artist celebrated for her heartfelt lyrics and soulful vocals that blend traditional gospel spirit with contemporary rhythms. She first gained recognition with her debut single, "Thank You," which resonated deeply with listeners through its message of gratitude and faith. In 2024, Jacqueline released the Thank You - EP, featuring standout tracks such as "Going Home," a poignant tribute to her late mother, and…
Why More People Are Choosing Mobile Hair and Beauty Services Through DashStylist …
People are seeking a means of making their lives easier in the hectic world we all live in. Mobile beauty and hair services are one of the trends that are on the rise. These services help save time and efforts as the salon experience has been delivered to the home of the customer. Customers do not have to drive to a salon, wait until their turn comes and then drive…
More Releases for Actinic
Actinic Keratosis Market Emerging Trends and Growth Prospects 2034
Introduction
Actinic keratosis (AK), also known as solar keratosis, is one of the most common precancerous skin conditions caused by long-term ultraviolet (UV) radiation exposure. It primarily affects older adults with fair skin and is considered a precursor to squamous cell carcinoma, making early detection and treatment critical. With rising awareness of skin cancer prevention, growing dermatology consultations, and expanding therapeutic innovations, the global actinic keratosis market is experiencing significant growth.
Over…
Actinic Keratosis Treatment Market Analysis, Size, Share & Trends | 2031
In recent years, the global Actinic Keratosis Treatment Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Actinic Keratosis Treatment Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Global Actinic Keratosis Market Report Forecast to 2027
A rough, scaly area on the skin called an actinic keratosis Market develops after years of sun exposure. It commonly appears on the cheeks, lips, ears, forearms, scalp, neck, and backs of the hands. An actinic keratosis, also known as a sun keratosis, develops slowly and generally appears in persons over the age of 40. By limiting your sun exposure and protecting your skin from ultraviolet (UV) radiation, you…
Actinic Keratosis Market Insight, Epidemiology and Market Forecast -2026
The report studies the global Actinic Keratosis Market with many aspects of the industry like the market size, market status, market trends, and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. The report offers valuable insight into the Actinic Keratosis Market progress and approaches related to the market with an analysis of each region. The report goes on to…
Actinic Keratosis Treatment Market Growing Trends and Demands Analysis
The Global Actinic Keratosis Treatment Market is projected to increase at a compound annual growth rate of over 4% between 2018 and 2027. With the increased prevalence of actinic keratosis, demand for its therapeutic medications have also sprung upwards. Actinic keratosis remains an extremely common condition and its existence can be traced all over the world, however people living in countries with thinner ozone layer cover are more prone to…
United States Actinic Keratosis Treatment Market Report 2016
MarketResearchReports.biz has recently announced the addition of a market study “ United States Actinic Keratosis Treatment Market Report 2016 ”, is a comparative analysis of the global market.
Notes:
Sales, means the sales volume of Actinic Keratosis Treatment
Revenue, means the sales value of Actinic Keratosis Treatment
This report studies sales (consumption) of Actinic Keratosis Treatment in United States market, focuses on the top players, with sales, price, revenue and market…
